First Time Loading...

Fortress Biotech Inc
NASDAQ:FBIO

Watchlist Manager
Fortress Biotech Inc Logo
Fortress Biotech Inc
NASDAQ:FBIO
Watchlist
Price: 1.91 USD 8.52% Market Closed
Updated: May 17, 2024

Fortress Biotech Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fortress Biotech Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Fortress Biotech Inc
NASDAQ:FBIO
Gross Profit
$57.9m
CAGR 3-Years
23%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$20.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.6B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is Fortress Biotech Inc's Gross Profit?
Gross Profit
57.9m USD

Based on the financial report for Dec 31, 2023, Fortress Biotech Inc's Gross Profit amounts to 57.9m USD.

What is Fortress Biotech Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
23%

Over the last year, the Gross Profit growth was 29%. The average annual Gross Profit growth rates for Fortress Biotech Inc have been 23% over the past three years , 23% over the past five years .